Stopping High Risk Life Sciences Research - Working Group Reports and Toolkit Discussion
Program Overview
BSAA working groups will share their findings and recommendations and discuss the tools they have developed. Participants will explore how these resources may support institutional review, research oversight, and policy implementation. The session will provide an opportunity to ask questions about the working groups’ reports, the tools, and their potential use within institutional programs.
Webinar Agenda
✔ BSAA working group reports and recommendations
✔ Discussion of tools developed by the working groups and their institutional use
✔ Live questions and answers with the working groups and BSAA faculty
Who Should Attend
- Biosafety Officers and Biosafety Professionals
- Institutional Biosafety Committee (IBC) Administrators and Members
- Research Compliance Professionals
- Anyone responsible for reviewing, managing, or overseeing potentially high-risk life sciences research
Why Attend
✔ Hear findings and recommendations from the BSAA working groups
✔ Learn about the tools the working groups have developed
✔ Discuss how these resources may support your institution’s implementation efforts
✔ Explore practical questions about institutional review and oversight
✔ Ask questions and exchange perspectives with BSAA colleagues
Key Takeaway
Participants will gain a clearer understanding of the working groups’ recommendations and the tools available to support institutional planning and implementation, with an opportunity to discuss questions and practical applications.
Standing BSAA Faculty
Bill Greer
Assistant Vice President for Research, University of Michigan
Bill Greer is a nationally recognized leader in research compliance with more than 35 years of experience spanning academia, industry, and nonprofit professional organizations. At the University of Michigan, he oversees institutional programs for animal care and use, biosafety, laboratory safety, controlled substances, and emerging autonomous systems.
Bill began his career in industry as a production manager and safety director at Intervet (formerly Tri Bio Laboratories) before transitioning to higher education, where he has held senior roles including Associate Director for Research Compliance, IACUC Vice-Chair, and Biosafety Committee Chair at The Pennsylvania State University. He earned his degree in Microbiology from The Pennsylvania State University.
In 2005, Bill founded the Research Administrators’ Best Practice Meetings, creating a nationally respected forum for research oversight professionals to address real-world programmatic challenges. He continues to facilitate multiple Best Practice Meetings annually focused on biosafety and animal care and use programs.
Bill also chaired the founding committee of the IACUC Administrators Association (IAA) in 2010 and continues to serve as its president and board chair. Since 2007, he has served as an ad hoc consultant to AAALAC International, conducting institutional program reviews and assessments. A frequent speaker and educator, Bill regularly presents at PRIM&R, AALAS, BTAA, C3, and BSAA-sponsored programs, supporting both IBC and IACUC administrative communities nationwide.
Jonah Lee, PhD
Senior Associate Director, University of Michigan
Dr. Jonah Lee brings deep scientific expertise and administrative leadership to biosafety and animal research oversight, with a strong focus on enhancing researcher experience while maintaining regulatory rigor. In his role at the University of Michigan, he provides thought leadership, program oversight, and process optimization across the Animal Care & Use Program.
Working closely with research administration and academic leadership, Dr. Lee leads the strategic development of research engagement infrastructure and institutional support resources. His background in biomedical sciences includes extensive research in stem cell biology and regenerative medicine, with a focus on aging skeletal muscles.
Dr. Lee completed postdoctoral training at the Center for Muscle Biology at the University of Kentucky and has led federally funded research involving both small and large animal models across multiple departments. His combined experience as a scientist and administrator brings a practical, researcher-informed perspective to biosafety and compliance discussions.
Andrew Maksymowych, PhD
Associate Director, Biosafety Programs, University of Pennsylvania
Andrew Maksymowych has more than three decades of experience in research, teaching, and biosafety oversight. Since 2006, he has served at the University of Pennsylvania as Associate Director for Biological Safety Programs, Institutional Biosafety Officer, IBC Administrator, and Institutional Contact for Dual Use Research.
Andrew serves on multiple institutional advisory committees, including the Vice Provost for Research Human Research Advisory Committee, the Human Stem Cell Research Advisory Committee, and the Cadaver and Body Parts Oversight Committee. He holds a B.S. and M.S. from Villanova University and a PhD in Biochemistry from Bryn Mawr College.
Prior to Penn, Andrew held a faculty appointment at Thomas Jefferson University, where his research focused on protein structure-function relationships, including neurotoxins affecting the human nervous system - most notably botulinum neurotoxins. An active BSAA contributor since attending his first Best Practice Meeting in 2015, Andrew remains deeply engaged in advancing biosafety education and professional collaboration.
Raymond F. Scheetz, MS, RBP
Institutional Biosafety Officer & Compliance Manager, Penn State College of Medicine
Ray Scheetz serves as Institutional Biosafety Officer and Compliance Manager at the Penn State College of Medicine within the Research Quality Assurance Office. He oversees all aspects of biosafety compliance, including protocol reviews, biosafety training, annual laboratory surveys, emergency response coordination, and equipment and asset management.
Ray is an active member of the Institutional Biosafety Committee, Research Mission Team, and institutional research emergency task forces. In addition to his institutional role, he serves as a biosafety consultant for Clinical Biosafety Services (CBS) / Shield Consulting.
Previously, Ray spent 25 years as a Laboratory Manager in the Department of Microbiology and Immunology at Penn State College of Medicine, where he managed a BSL-3 facility and supported complex infectious disease research programs. His extensive operational experience provides a grounded, practical perspective on biosafety program implementation.
The meeting will occur in Eastern Time.
| Non-Members Fee | $85.00 |
| Members Fee | $0.00 |